Driven by our mission to end cancer, MD Anderson researchers developed new therapies, analyzed vast data sets, solved medical mysteries and more over the last year. These breakthroughs across the spectrum of cancer research can make immediate impacts on the lives of patients and shape the future of cancer care.
To expand the reach of these transformational breakthroughs, MD Anderson increased its visibility at national industry...
Since radiation therapy was first used to treat cancer over a century ago, clinicians have sought the right balance between maximizing the...
Since the discovery of cyclin-dependent kinases (CDKs), a family of proteins vital in the early stages of cell development, scientists have...
When a patient receives a cancer diagnosis, one of the things their doctor might refer to is whether their cancer has microsatellite instability, or MSI. The prognosis and response to immunotherapy tend to be better for cancers that have high MSI, but why?
To learn more about MSI, we spoke with gastrointestinal medical oncologist and researcher Jason Willis, M.D., Ph.D.
First, what is a microsatellite?DNA is held...
